240 related articles for article (PubMed ID: 15611370)
1. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R
Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
[TBL] [Abstract][Full Text] [Related]
3. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Davies JK; Wells DJ; Liu K; Whitrow HR; Daniel TD; Grignani R; Lygate CA; Schneider JE; Noël G; Watkins H; Carling D
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1942-51. PubMed ID: 16339829
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Daniel T; Carling D
J Biol Chem; 2002 Dec; 277(52):51017-24. PubMed ID: 12397075
[TBL] [Abstract][Full Text] [Related]
7. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
Gollob MH; Green MS; Tang AS; Roberts R
Curr Opin Cardiol; 2002 May; 17(3):229-34. PubMed ID: 12015471
[TBL] [Abstract][Full Text] [Related]
8. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
Gollob MH; Green MS; Tang AS; Gollob T; Karibe A; Ali Hassan AS; Ahmad F; Lozado R; Shah G; Fananapazir L; Bachinski LL; Roberts R
N Engl J Med; 2001 Jun; 344(24):1823-31. PubMed ID: 11407343
[TBL] [Abstract][Full Text] [Related]
9. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
[TBL] [Abstract][Full Text] [Related]
12. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen.
Folmes KD; Chan AY; Koonen DP; Pulinilkunnil TC; Baczkó I; Hunter BE; Thorn S; Allard MF; Roberts R; Gollob MH; Light PE; Dyck JR
Circ Cardiovasc Genet; 2009 Oct; 2(5):457-66. PubMed ID: 20031621
[TBL] [Abstract][Full Text] [Related]
13. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
[TBL] [Abstract][Full Text] [Related]
15. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
16. Significance of ventricular pacing site in manifest entrainment during orthodromic atrioventricular reentrant tachycardia with left-sided accessory pathway.
Suyama K; Ohe T; Kurita T; Maruyama T; Takaki H; Aihara N; Kamakura S; Shimizu W; Matsuhisa M; Shimomura K
Pacing Clin Electrophysiol; 1992 Aug; 15(8):1114-21. PubMed ID: 1381078
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
Miyamoto L
J Med Invest; 2018; 65(1.2):1-8. PubMed ID: 29593177
[TBL] [Abstract][Full Text] [Related]
18. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.
Wolf CM; Arad M; Ahmad F; Sanbe A; Bernstein SA; Toka O; Konno T; Morley G; Robbins J; Seidman JG; Seidman CE; Berul CI
Circulation; 2008 Jan; 117(2):144-54. PubMed ID: 18158359
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
